Details

Last Funding Type

Grant

Industries

Artificial Intelligence,Biotechnology,Health Care,Machine Learning,Medical,Pharmaceutical

Founded date

Feb 1, 2021

Number Of Employee

11 - 50

Operating Status

Active

Legal Name

RECEPTOR.AI

Receptor.AI is committed to pushing the boundaries of precision medicine by developing a pipeline of novel small molecules that possess ultimate selectivity in targeting highly similar disease-related proteins such as homologs, mutants, isoforms, and allele variations.

Our proprietary five-level selectivity assessment engine is designed to laser-focus on protein variants specific to particular human populations, organs, tissues and tumour types, ensuring precise alignment with patient profiles.

Receptor.AI platform combines experimental structure determination techniques and AI-augmented medicinal chemistry, unlocking allosteric and cryptic binding pockets and unravelling protein conformational flexibility, making it possible to discriminate between otherwise indistinguishable targets and off-targets.